Effects of metformin combined with insulin aspart on gestational weight gain, lipid metabolism, immune function, and delivery outcomes in pregnant women with gestational diabetes

Metformin combined with insulin aspart demonstrates significant therapeutic benefits in treating GDM. It effectively regulates blood glucose and lipid metabolism, controls weight gain, enhances immune function, reduces insulin resistance, suppresses inflammation, and lowers the incidence of adverse delivery outcomes, with good drug safety.